Martin Shkreli Ain’t Nothing To Fuck With

Martin Shkreli is a local celebrity. The fame of this 32-year old internet live-streaming, World of Warcraft playing, Wu-Tang album buying, OkCupid prowling, pharmacy executive has gone from 0 to 60 in just a few months.  

We learned earlier this month that Martin dropped a couple million dollars on the only copy of Wu-Tang’s latest album, Once Upon a Time in Shaolin. And he’s better known for his antics with hiking drug prices.

However, as it turns out, Martin might be a better short-seller than anything else. Notable names Martin has been short includes the likes of Horizon Pharma, Zalicus, Oncothyreon, Vital Therapies, Avanir Pharma and Neoprobe  – all of which are down more than 30 percent since Martin went short. He’s also been short a number of other biotechs that he’s made money on.

Martin’s performance as a short seller tops what the likes of Citron Research, David Einhorn and Jim Chanos have done on the short side..

In short, if Martin shows up in one of your pharma stocks – GTFO – whether he’s long or short.